QR Kod

The novel proteomic signature for cardiac allograft vasculopathy

Abstract Aims Cardiac allograft vasculopathy (CAV) is the major long‐term complication after heart transplantation, leading to mortality and re‐transplantation. As available non‐invasive biomarkers are scarce for CAV screening, we aimed to identify a proteomic signature for CAV. Methods and results...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Dongmei Wei, Sander Trenson, Jan M. Van Keer, Jesus Melgarejo, Ella Cutsforth, Lutgarde Thijs, Tianlin He, Agnieszka Latosinska, Agnieszka Ciarka, Thomas Vanassche, Lucas Van Aelst, Stefan Janssens, Johan Van Cleemput, Harald Mischak, Jan A. Staessen, Peter Verhamme, Zhen‐Yu Zhang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2022-04-01
Seri Bilgileri:ESC Heart Failure
Konular:
Heart transplantation
Cardiac allograft vasculopathy
Biomarkers
Proteomics
Diagnosis
Online Erişim:https://doi.org/10.1002/ehf2.13796
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller